KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
130 이균민 교수 생명과학과 학과장 취임 과사무실 2007.09.13 12597
129 이균민 교수, 교무처장 인사 발령 과사무실 2010.07.15 11803
128 이상기 박사 한국생명공학연구원장 취임 과사무실 2005.07.12 13553
127 이상열 교수(박사 85) KAIST 올해의 동문 선정 과사무실 2005.01.04 15169
126 이승재 교수, 올리브유의 노화 방지 및 장수 효과 입증 file 생명과학과 2019.08.22 5615
125 이승재 교수, 한성과학상 수상 file 생명과학과 2019.07.01 6237
124 이승재 교수님_One More Key to Human Longevity Found After Worm Research 생명과학과 2020.07.03 10806
123 이승희 교수, 송유향, 김재현 박사과정 학생 Neuron 게재 file 생명과학과 2017.02.13 17750
122 이승희 교수님_KAIST, 뇌 인지기능 높이는 물질 발견… 치매 치료 효과 기대 file 생명과학과 2020.04.26 4939
121 이승희 교수님_시각 정보 인식해 행동 결정하는 대뇌 신경회로 과정 밝혀 생명과학과 2021.08.30 480
120 이주용 박사, 김세윤 교수, PNAS지에 논문 게재 / PhD Joo-Yong Lee and Prof, Seyun Kim published a paper in PNAS 생명과학과 2016.07.04 16339
119 이준식 교수 IAFOST Fellow 선출 과사무실 2003.09.08 13390
118 이중재 박사와 김학성 교수 연구팀, Theranostics에 표지 논문 발표 file 생명과학과 2017.08.18 12643
117 인선아 박사과정 학생. 제 18차 KHUPO 프로테오믹스 국제학술대회 수상 file 생명과학과 2018.04.13 12771
116 임대식 교수 국가지정연구실사업 신규과제 선정 과사무실 2005.03.30 11447
115 임대식 교수 논문 Nature Cell Biology 게재 1 과사무실 2004.01.26 13650
114 임대식 교수 외 3명 개교 34주년 기념 우수교원 포상 과사무실 2005.02.15 10868
113 임대식 교수, 2016년도 한국분자세포생물학회 정기학술대회 학술상 생명과학상 소개 강연 생명과학과 2016.10.10 13645
112 임대식 교수, EMBO Journal 에 논문 게재 (2012.3.7) 과사무실 2012.04.17 12687
111 임대식 교수, KAIST 지정 석좌교수 임용 과사무실 2014.02.25 11970
Board Pagination Prev 1 ... 11 12 13 14 15 16 17 18 19 20 ... 22 Next
/ 22